Aside from these well-established lipid/lipoprotein markers, the interest in surrogate markers, particularly of diabetes-associated risk, e.g., insulin resistance (IR), has been growing and offers a number of evaluations directly assessing insulin levels, such as the homeostatic model assessment for insulin resistance (HOMA-IR) index and others [4]. Here, INS is linked to Insulin resistance.